Skip to Content

Navitus' 2021 Drug Trend Report Reveals Significant Cost Savings and Improved Member Health

  • Jun 16, 2022
  • PBM Model
MADISON, Wis., June 16, 2022 – Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) that’s committed to bringing humanity to pharmacy benefits management, released its 2021 Annual Drug Trend Report demonstrating pharmacy benefit cost savings for its customers and improved affordability for members. Navitus’ new report shows that new clients who moved to Navitus from another PBM in 2021 saved an average of 16%, with additional data on existing clients that savings continued years two through six after implementation.

“At Navitus, we exist to help people access important medication therapies at affordable costs so they can live their fullest lives,” said Brent Eberle, RPh, MBA, Senior Vice President and Chief Pharmacy Officer. “By partnering and aligning with our customers to help them save on pharmacy benefit costs and to improve health outcomes, we work towards our mission of helping humanity.”

The rising costs of medications are a top concern for most Americans. In fact, 30% of adults have not taken their medications as prescribed at least once in the past year because of cost - putting their health and well-being at risk.1 Navitus’ 100% pass-through, lowest-net-cost philosophy and clinical care programs are designed to achieve greater medication affordability and adherence for members. According to the 2021 Annual Drug Trend Report, commercial plans achieved an all-in, total-net-cost per member per month (PMPM) cost of $84.37 with Navitus, a modest year-over-year increase of 1.5%.2  

“Over the last five years, new clients have realized first-year savings ranging from 16% to 25%. Each year, we are delivering more value to plans and their members, and doing the right thing for health care consumers,” said Tom Pabich, Senior Vice President, Business Development & Client Services. “They are also pleased with the outstanding level of customer service as reflected in our superstar Net Promoter Score rating again this year.”

Key highlights from the report reveal: 
  • Outstanding service- Navitus’ client Net Promoter Score (NPS) increased to 76 from 72 in the prior year. 
  •  Stellar implementation – Navitus clients reported 100% satisfied post implementation.3 
  • Well-controlled drug spend:
    • The dataset revealed non-specialty drug trend of -0.9% in 2021, reflecting how unit cost reduction offset increased utilization.
    • Lower specialty unit cost, keeping specialty trend to 4.3%, the lowest in recent years.
To access the full 2021 Navitus Drug Trend Report, download a copy here.

About Navitus
Navitus Health Solutions, owned by SSM Health and Costco Wholesale Corporation, is a disruptive industry alternative to traditional pharmacy benefit manager (PBM) models. As such, Navitus is committed to taking costs out of the drug supply chain - not shifting them - to make prescriptions more affordable for 8.5 million consumers through nearly 1,000 plan sponsors (i.e., employers, health plans, unions, governments, etc.). By returning 100% of rebates and discounts received and deploying a lowest-net-cost philosophy, Navitus helps reduce costs and improve member health. To learn more about Navitus, call 877.571.7500 or visit Follow Navitus on Twitter and LinkedIn to stay up-to-date on all the latest pharmacy benefit news, information and expert analysis.

For media inquiries, contact  


1 Public Opinion on Prescription Drugs and Their Prices. Kaiser Family Foundation. Published April 5, 2022. Accessed May 4, 2022.
All-in, net-cost PMPM was calculated from Navitus commercial clients, including employers of all types (retail, manufacturing, government, school districts) and commercial health plans, and comprised of different and varied health populations.
Navitus 2021 implementation satisfaction survey.

Associated People